Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-20
    E.g., 2018-10-20

Archive Search

1 results
12:00 AM, Sep 10, 2009  |  BC Innovations | Distillery Therapeutics

Indication: Pulmonary disease

bronchoconstriction-associated conditions. GlaxoSmithKline plc has two muscarinic acetylcholine antagonists in Phase II testing for COPD: darotropium